ArticleFrontiers in immunology2022

Fatty Acid Metabolic Signaling Pathway Alternation Predict Prognosis of Immune Checkpoint Inhibitors in Glioblastoma.

Rongrong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.